Lancet Capital

Lancet Capital is a venture capital firm in Massachusetts that focuses on investing in biomedical technologies, bio-informatics, biopharmaceuticals, medical devices, medical information systems, medical therapeutics and diagnostic systems. Founded 1998 in Cambridge, Massachusetts, United States by George Sing and William Golden. Its portfolio companies include Biodel and Stentor. Lancet invests in researchers, clinicians and entrepreneurs to commercialize innovative technologies in the biomedical field. It is an SBIC that is affiliated with an academic medical center and aims to commercialize technologies in the biomedical field.